Publication Name	World Journal of Nephrology
Manuscript ID	119286
Country	Ethiopia

Category	Urology & Nephrology
Manuscript Type	Letter to the Editor
Article Title	Enhancing renin-angiotensin-aldosterone system inhibitors utilization through patiromer adherence: Real-world insights for nephrology practice
Manuscript Source	Invited Manuscript
All Author List	Gemechu Dereje Feyissa
Funding Agency and Grant Number
Corresponding Author	Gemechu Dereje Feyissa, Assistant Professor, Department of Public Health, Faculty of Health Sciences, Rift Valley University, Hangatu District, Dabe Sub-City, Adama 1715, Oromīa, Ethiopia. gemechudereje80@gmail.com
Key Words	Renin-angiotensin aldosterone system inhibitors; Patiromer adherence; Hyperkalemia management; Chronic kidney disease; Nephrology practice
Core Tip	Among 13447 real-world patiromer users, high adherence [proportion of days covered (PDC) ≥ 80%] drove approximately 10% higher renin-angiotensin-aldosterone system inhibitors utilization (Table 1). Prioritize chronic patiromer (Kidney Disease: Improving Global Outcomes 2021/OPAL-HK), monitor PDC, use multidisciplinary support to overcome barriers, and combine with SGLT2i/finerenone for renal/cardiovascular protection.
Citation	Feyissa GD. Enhancing renin-angiotensin-aldosterone system inhibitors utilization through patiromer adherence: Real-world insights for nephrology practice. World J Nephrol 2026; In press

Received	2026-01-23 02:38
Peer-Review Started	2026-01-23 02:46
First Decision by Editorial Office Director	2026-01-28 09:11
Return for Revision	2026-01-28 09:11
Revised	2026-01-30 19:20
Publication Fee Transferred
Second Decision by Editor	2026-02-25 02:36
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2026-02-25 07:31
Articles in Press	2026-02-25 07:31
Edit the Manuscript by Language Editor
Typeset the Manuscript

ISSN	2220-6124 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com